Experts call for additions to strengthen act amending drug legislation

Several experts say the federal government’s attempt to strengthen the powers of the Food and Drug Act haven’t gone far enough. They applaud some of the provisions in Bill C-17, but say additional powers are needed to protect the public.

Several experts say the federal government’s attempt to strengthen the powers of the Food and Drug Act haven’t gone far enough.

They applaud some of the provisions in Bill C-17, but say additional powers are needed to protect the public.

They make their argument in a commentary published in this week’s issue of the Canadian Medical Association Journal.

The act, which was introduced in Parliament in early December, gives the federal health minister long-overdue powers to order the recall of a drug for safety reasons.

Currently Health Canada must negotiate recalls with drug manufacturers, which can result in a drug remaining on the market after it has been deemed to be dangerous. The researchers worry that the proposed amendments say recalls can be unilaterally ordered when evidence shows a drug is unsafe; they say the minister should be able to act when he or she has reasonable grounds to believe the drug could cause harm.

They also suggest the legislation should exempt the health minister from liability on drug suspensions and recalls, saying that without it the threat of being sued would be a strong disincentive to use the recall power.

The lead author of the commentary was Matthew Herder, who teaches health law in Dalhousie University’s faculty of medicine. He and his co-authors argue that the act should address the need for greater transparency in the data drug companies derive from the clinical trials they conduct.

The U.S. and Europe require that clinical trials are registered — a move Canada has not followed to date. Health Canada maintains a database of clinical trials, but stipulates it is not a registry and doesn’t contain comprehensive information about all clinical trials. The authors suggest the data from these trials should be available for scrutiny by researchers.

They also call for more transparency on the part of Health Canada, saying the regulator should make public the rationale for its decisions — and, in fact, should make all its decisions public. Currently Health Canada does not disclose when it has turned down a drug application, though its European counterpart does release negative opinions.

As the legislation currently stands — or is interpreted — too much information that the public needs is withheld on the grounds it is proprietary or is a trade secret, the commentary notes.

“These assertions overstate what the law actually requires and prevent important information about safety and effectiveness from being released,” the authors write. “Bill C-17 should explicitly state that the results of clinical trials, including de-identified patient level data, post-marketing studies and adverse drug reactions reported by drug manufacturers and health-care institutions are not proprietary and therefore should be publicly disclosed.”

Just Posted

Updated: SUV smashes through fences and deck in Anders

Driver taken to hospital after SUV veered off 30th Avenue into Anders

Art on Red Deer billboard a reminder of aboriginal women’s strength

Joane Cardinal-Schubert’s image is part of Resilience Project, shown from coast to coast

Red Deer’s new ‘equity co-ordinator’ will promote tolerance

Andrea Lacoursiere was hired by city with Alberta Human Rights funding

More bridge work this summer in Red Deer’s Coronation Park

The park’s north bridge is being rebuilt to ensure safety

Man badly injured in off-road vehicle collision on Saturday

Incident happened in Mountain View County about 10:50 p.m.

CFIA inspects after video shows pigs crammed into B.C. transport truck

The video shows pigs piled on top of one another in a transport truck on a “sweltering” hot day last week

Cubs’ Kyle Schwarber falls to Bryce Harper in Home Run Derby final

WASHINGTON — Nationals Park was eerily quiet late Monday when Kyle Schwarber… Continue reading

Lava crashes through roof of Hawaii tour boat, injuring 23

HONOLULU — An explosion caused by lava oozing into the ocean sent… Continue reading

Banff holds blessing ceremony with Indigenous elders before letting bison roam

BANFF, Alta. — Several Indigenous elders were flown by helicopter into the… Continue reading

Research expedition looks at unseen depths of Labrador Sea ecosystem

ST. JOHN’S, N.L. — Last summer, a team of scientists returned from… Continue reading

Protesters camped outside Saskatchewan legislature taking province to court

REGINA — Protesters camped outside the Saskatchewan legislature say they are taking… Continue reading

British PM accepts key amendments from hardline Brexiteers

LONDON — British Prime Minister Theresa May on Monday accepted amendments to… Continue reading

‘City of icebergs:’ Study says 100s of Arctic glaciers shrinking, disappearing

The statistics in her recently published paper say it all: hundreds of… Continue reading

U.S. hits back with WTO challenge against Canada’s retaliatory tariffs

OTTAWA — The United States fired back Monday at the Canadian government’s… Continue reading

Most Read


Five-day delivery plus unlimited digital access for $185 for 260 issues (must live in delivery area to qualify) Unlimited Digital Access 99 cents for the first four weeks and then only $15 per month Five-day delivery plus unlimited digital access for $15 a month